Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
921.30
3.40 (0.37%) Natco Pharma - Quaterly Results
Date: 27-05-2024
The revenue for the March 2024 quarter is pegged at Rs. 9648.00 millions, about 23.50% up against Rs. 7812.00 millions recorded during the year-ago period.A good growth in profit of 37.39% reported to Rs. 3491.00 millions over Rs. 2541.00 millions of corresponding previous quarter.Operating profit surged to 4886.00 millions from the corresponding previous quarter of 3452.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var | |
| Sales | 9648.00 | 7812.00 | 23.50 | 35689.00 | 23510.00 | 51.80 | 35689.00 | 23510.00 | 51.80 |
| Other Income | 359.00 | 175.00 | 105.14 | 1047.00 | 855.00 | 22.46 | 1047.00 | 855.00 | 22.46 |
| PBIDT | 4886.00 | 3452.00 | 41.54 | 17417.00 | 9302.00 | 87.24 | 17417.00 | 9302.00 | 87.24 |
| Interest | 45.00 | 12.00 | 275.00 | 145.00 | 86.00 | 68.60 | 145.00 | 86.00 | 68.60 |
| PBDT | 4841.00 | 3440.00 | 40.73 | 17272.00 | 9216.00 | 87.41 | 17272.00 | 9216.00 | 87.41 |
| Depreciation | 516.00 | 376.00 | 37.23 | 1719.00 | 1509.00 | 13.92 | 1719.00 | 1509.00 | 13.92 |
| PBT | 4325.00 | 3064.00 | 41.16 | 15553.00 | 7707.00 | 101.80 | 15553.00 | 7707.00 | 101.80 |
| TAX | 834.00 | 523.00 | 59.46 | 2487.00 | 1336.00 | 86.15 | 2487.00 | 1336.00 | 86.15 |
| Deferred Tax | -2.00 | 24.00 | -108.33 | -361.00 | 5.00 | -7320.00 | -361.00 | 5.00 | -7320.00 |
| PAT | 3491.00 | 2541.00 | 37.39 | 13066.00 | 6371.00 | 105.09 | 13066.00 | 6371.00 | 105.09 |
| Equity | 358.00 | 365.00 | -1.92 | 358.00 | 365.00 | -1.92 | 358.00 | 365.00 | -1.92 |
| PBIDTM(%) | 50.64 | 44.19 | 14.61 | 48.80 | 39.57 | 23.34 | 48.80 | 39.57 | 23.34 |